Invention Grant
- Patent Title: Selegiline transdermal system
- Patent Title (中): 司来吉兰透皮系统
-
Application No.: US13866278Application Date: 2013-04-19
-
Publication No.: US09539201B2Publication Date: 2017-01-10
- Inventor: Kirti H. Valia , Thomas Mark Rossi , Agis Kydonieus
- Applicant: KAT Transdermals LLC
- Applicant Address: US NJ Kendall Park
- Assignee: KAT Transdermals LLC
- Current Assignee: KAT Transdermals LLC
- Current Assignee Address: US NJ Kendall Park
- Agency: Hoffman Warnick LLC
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K31/137 ; A61K9/00 ; A61K9/70
Abstract:
Embodiments of the invention relate generally to the field of transdermal delivery and more specifically to transdermal patches containing selegiline base for the treatment of depression, Parkinson's disease, and other nervous system conditions.
Public/Granted literature
- US20130281542A1 SELEGILINE TRANSDERMAL SYSTEM Public/Granted day:2013-10-24
Information query
